alexa Spectrophotometric Determination of Some Antibiotics Using Bromophenol Blue as Ion Pair Reagent | OMICS International
ISSN : 2153-2435
Pharmaceutica Analytica Acta
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Spectrophotometric Determination of Some Antibiotics Using Bromophenol Blue as Ion Pair Reagent

Ravin Jugade* and Mrudul Keskar

Department of Chemistry, R. T. M. Nagpur University, Nagpur 440033, India

*Corresponding Author:
R M Jugade
Department of Chemistry
R. T. M. Nagpur University
Nagpur 440033, India
Tel: +91 9420254377
E-mail: [email protected]

Received Date: May 23, 2015; Accepted Date: June 02, 2015; Published Date: June 09, 2015

Citation: Jugade R, Keskar M (2015) Spectrophotometric Determination of Some Antibiotics Using Bromophenol Blue as Ion Pair Reagent. Pharm Anal Acta 6:380. doi: 10.4172/2153-2435.1000380

Copyright: ©2015 Jugade R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Pharmaceutica Analytica Acta


Objective: Simple and rapid methods have been developed for the determination of azithromycin, sparfloxacin and cephalexin monohydrate in bulk and pharmaceutical formulations. Method: These methods were based on the formation of bluish-green ion pair complexes of these antibiotics with bromophenol blue (BPB). Acetonitrile was used as a solvent for azithromycin and sparfloxacin whereas methanolacetonitrile medium for cephalexin monohydrate. Results: 2:1 complexes were formed between the drug and reagent almost instantaneously with absorption maxima 595 nm, 620 nm, 600 nm for the three drugs respectively. Different parameters such as effect of time, effect of reagent concentration were optimised. Under optimum conditions, calibration curves were found to be linear over the range of 0-50 μg mL-1 for azithromycin, 10-80 μg mL-1 for sparfloxacin and 10-170 μg mL-1 for cephalexin monohydrate respectively. The detection limits were found to be 0.10 μg mL-1, 0.21 μg mL-1 and 1.69 μg mL-1 with Sandell’s sensitivity 0.0559 μg cm-2, 0.1034 μg cm-2 and 1.3920 μg cm-2 respectively for the three drugs. Stability constant (log K) was found to be 6.19 ± 0.04, 5.00 ± 0.07 and 4.05 ± 0.05 showing high stability of the complexes. Molar absorptivity was found to be 1.369×104 L mol-1 cm-1, 3.774×103 L mol-1 cm-1 and 2.620×102 L mol-1 cm-1 with Gibb’s free energy change -2.725×103 kJ mol-1, -2.393×103 kJ mol-1 and -1.938×103 kJ mol-1. These methods were subjected to analytical quality control. Accuracy, precision, recovery and interference studies have been carried out. Conclusion: The proposed methods were successfully applied to the determination of these drugs in their pharmaceutical formulations and human urine samples.


Azithromycin; Sparfloxacin; Cephalexin monohydrate; Bromophenol blue; Ion pair complex; Pharmaceutical formulations; Urine sample


Azithromycin is an important member of macrolide class of antibiotics. It is European Pharmacopoeia recommended antibiotic [1]. Macrolides are a group of antibiotics that belongs to the polyketide class of natural products. Their activity stems from the presence of a macrolide ring, a 15-membered macrocyclic lactone ring to which one or more deoxy-sugars may be attached [2]. Sparfloxacin is third generation quinolone antibiotic. It is official in Martindale extra Pharmacopeia [3]. Due to the presence of fluorine atom at C-6 position of quinolone, this clinically useful quinolone is described as fluoroquinolone. It is active against both gram-positive and gram-negative bacteria. It is widely used to treat human and veterinary diseases [4,5]. Cephalexin monohydrate is first generation cephalosporin antibiotic. Mode of action of cephalexin monohydrate is same as that of β- lactam antibiotics; it inhibits the synthesis of peptidoglycan layer of bacterial cell wall [6]. It is antibacterial, used as alternative to penicillin. It is useful for bone joint infections, pneumonia, urinary tract infection and its common side effect is intestinal upset. It is European Pharmacopoeia recommended antibiotic [7].

Bromophenol blue (BPB) is a triphenylmethane dye and is commonly used as indicator and spectrophotometric reagent. The structures of the three antibiotics and bromophenol blue are shown in Figure1.


Figure 1: Structures of a) azithromycin, b) sparfloxacin, c) cephalexin monohydrate and d) bromophenol blue (BPB).

¨Several methods have been reported in literature for the analysis of azithromycin, sparfloxacin and cephalexin monohydrate such as HPLC [8], spectrofluorometry [9], capillary electrophoresis [10], voltammetry [11], etc.

Spectrophotometric method is based on the formation of coloured (charge transfer or ion-pair) complex between drug and reagent which can be estimated by visible spectrophotometer. In ion-pair complex, ions of opposite electric charge are held together in solution by Coulomb attraction to form a distinct chemical entity. It behaves as a single unit. Ion pair formation, initially investigated by the physical chemistry has been found extremely interesting for the chemical analysis, including pharmaceutical analysis. Reported spectrophotometric methods of these three antibiotics includes complex formation with quinalizarin [12], eosin Y [13], rose Bengal [14], chloranilic acid and 7,7,8,8-tetracyanoquinodimethane [15], bromocresol purple and bromecresol green [16], ammonium vanadate [17], p-nitro phenol [18], Mo(V)-thiocyanate [19], p- dimethyl aminobenzaldehyde [20], molybdenum blue [21], Sodium 1,2-napthoquinone-4-sulphonate [22], p-benzaquinone [23], iodine, 2,3-dichloro-5,6-dicyano-1,4- benzoquinone and 7,7,8,8-tetracyanoquinodimethane [24].

The proposed methods are based on formation of ion pair complexes with bromophenol blue. Bromophenol blue has been used for the first time with significantly low detection limit, high sensitivity and wider dynamic range. An important feature of these methods is that no extraction is required and it is feasible at room temperature. These methods could be applied to the analysis of pharmaceutical formulations and urine sample.



Spectrophotometric studies were carried out with Spectronic 20D+ (Thermo-Spectronic) visible spectrophotometer. A Mettler balance H 51AR (Ner-Parma instrument Corp. L.C. = 0.01mg) was used for weighing purpose.

Materials and reagents

All chemicals and reagents used were of analytical grade. Azithromycin, sparfloxacin and cephalexin monohydrate were obtained from ZIM laboratories. Bromophenol blue, HPLC grade acetonitrile and methanol were obtained from LOBA Chemie.

Preparation of solutions

Stock solutions of azithromycin or sparfloxacin were prepared as 0.01M in acetonitrile while 0.01M cephalexin monohydrate solution was prepared in methanol whereas 0.01M bromophenol blue solution was prepared in acetonitrile. The solutions were further diluted as per requirement.

Procedure for calibration curve

Suitable aliquots of azithromycin or sparfloxacin solutions in acetonitrile or cephalexin monohydrate in methanol were transferred into 10 ml volumetric flasks. To it, 2 ml of 8x10-5 M bromophenol blue solution for azithromycin, 5ml of 8x10-5 M bromophenol blue solution for sparfloxacin and 6ml of 5×10-5 M bromophenol blue solution for cephalexin monohydrate was added and volume was made up to 10 ml with respective solvents. This made the final concentration of bromophenol blue to 16 μM, 40 μM and 30 μM respectively. After 15, 10 and 5 minutes, for three drugs respectively, the absorbance of bluish-green solution was measured at 595 nm, 620 nm and 600 nm against the appropriate reagent blank.

Procedure for dosage form

For analysis of tablets or capsules, five tablets or capsules were weighed and average weight of one tablet or capsule was determined. They were powdered and 0.05 g of azithromycin and 0.04 g of cephalexin monohydrate exactly weighed and shaken with 30 ml of acetonitrile and methanol respectively for 30 minutes. These solutions were filtered with Whatmann filter paper no. 40 and made up to 50 ml with respective solvents. The same procedure was applied for oral suspension of azithromycin using 1ml suspension. Suitable aliquots were analysed using general procedure.

Procedure for urine sample

The urine samples were collected from healthy volunteer. In order to analyse urine samples, 10 ml of urine samples were spiked with azithromycin and sparfloxacin separately. The drugs were extracted with dichloromethane and evaporated to dryness. The residue was dissolved in respective solvents and analysed using general procedure.

Results and Discussion

Effect of solvent

Various solvents like methanol, ethanol, acetone, dichloromethane, dichloroethane, dimethylsulphoxide, chloroform and acetonitrile were used to check the solubility, complex formation, to achieve maximum sensitivity and product stability. Acetonitrile for azithromycin, sparfloxacin and bromophenol blue and methanol for cephalexin monohydrate were found to be most suitable solvents.

Absorption spectra

Solutions of azithromycin or sparfloxacin and bromophenol blue in acetonitrile and cephalexin monohydrate in methanol were prepared. Absorption spectra of these solutions were recorded individually. When the drug solutions were mixed with BPB solution, bluishgreen complexes were formed with absorption maxima at 595 nm for azithromycin, 620 nm for sparfloxacin and 600 nm for cephalexin monohydrate respectively (Figure 2). Under experimental conditions, the reagent as well as the drug showed negligible absorbance while the complexes showed maximum absorbance at these wavelengths. Hence, it was concluded that the studies for quantitative analysis could be carried out at these wavelengths.


Figure 2: Absorption spectra of drug, reagent and complexes: a) azithromycin (767 μg mL-1), BPB (80 μM) and their complex, b) cephalexin monohydrate (3654 μg mL-1), BPB (80 μM) and their complex and c) sparfloxacin (39 μg mL-1), BPB (80 μM) and their complex.

Stoichiometric relationship and stability studies

Composition and stability constants of these complexes were established by applying Job’s method of continuous variation. Equimolar solutions of the drug and the reagent were mixed in various proportions and absorbance of each mixture was recorded. The results indicated that the complexes are formed in the ratio of 2:1 (D:R) (Figure 3). Mechanism of formation of such complexes with composition (DH)+2 (R)2- has been discussed by Gainza and Konyeaso [25]. The suggested structure of ion pair complex of azithromycin can be shown as in Figure 4. Similar structures can be suggested for sparfloxacin as well as for cephalexin monohydrate. The stability constants (log K) values were found to be 6.19 ± 0.04 for azithromycin, 5.00 ± 0.07 for sparfloxacin and 4.05 ± 0.05 for cephalexin monohydrate respectively showing high stability of the complexes. The large negative values of Gibb’s free energy change for complex formation show spontaneity of process (Table 1).


Figure 3: Continuous variation plots for the ion pair complexes of azithromycin (3×10-5 M), cephalexin monohydrate (5x10-4 M) and sparfloxacin (1x10-4 M) with BPB.


Figure 4: Schematic representation of ion pair complex of azithromycin.

Parameters Azithromycin Sparfloxacin Cephalexin monohydrate
λmax(nm) 595 620 600
Molar ratio (D:R) 2:1 2:1 2:1
Linear range (μg mL-1) 0-50 10-80 10-170
Slope 0.0178 0.0096 0.0007
Intercept 0.0418 -0.1028 -0.0080
Sandell’s sensitivity (μg cm-2) 0.0559 0.1034 1.3920
Correlation coefficient 0.9871 0.9967 0.9992
Stability constant (log K) 6.19 ± 0.04 5.00 ± 0.07 4.05 ± 0.05
Molar absorptivity (L mol-1 cm-1) 1.369×104 3.774×103 2.620×102
LODa(μg mL-1 ) 0.10 0.21 1.69
LOQb (μg mL-1 ) 0.35 0.71 5.63
%RSDc(at 10 μg mL-1) 0.55 0.33 3.06
ΔGod(kJ mol-1) -2.725×103 -2.393×103 -1.938×103

Table 1: Qualitative and statistical parameters for proposed methods.

Effect of time

Mixtures of drug and reagent were prepared; the optimum reaction time was determined by recording the absorbance of the formed complexes at different time intervals. The variation has been shown in Figure 5. It was found that the complexes were formed instantaneously at room temperature. The absorbance was found to be steady after 15, 5 and 20 minutes for azithromycin, sparfloxacin and cephalexin monohydrate respectively. Hence, in order to remove time effect, all observations were made after respective time interval of complex formation. The sample solutions were kept in air tight flasks to avoid any evaporation losses.


Figure 5: Effect of time on the absorbance of ion pair complexes of azithromycin, cephalexin monohydrate and sparfloxacin with BPB.

Effect of reagent concentration

The optimum concentration of bromophenol blue was determined by adding various concentrations of bromophenol blue to the drugs. The colour intensity was found to increase with addition of bromophenol blue up to a particular concentration and then either decrease or remain steady. The absorbance was found to be maximum at bromophenol blue concentration of 16 μM for azithromycin, 40 μM for sparfloxacin and 30 μM for cephalexin monohydrate. Therefore, these concentrations were used to prepare calibration curve (Figure 6).


Figure 6: of BPB concentrations on ion pair complexes of azithromycin (100 μg mL-1), cephalexin monohydrate (100 μg mL-1) and sparfloxacin (100 μg mL-1).

All the observations were made in triplicate and mean of the three values have been plotted in each graph.

Analytical parameters

Calibration curves for azithromycin, sparfloxacin and cephalexin monohydrate were plotted between absorbance and concentration. A linear absorbance-concentration correlation was found to be 0-50 μg mL-1, 10-80 μg mL-1 and 10-170 μg mL-1 with correlation coefficients 0.9871, 0.9967 and 0.9992 respectively for the three drugs. The molar absorptivity values were found to be 1.369×104, 3.774×103 and 2.620×102 L mol-1 cm-1 respectively. The limit of detection and limit of quantitation were calculated in accordance with equations,

LOD = 3σ/S

LOQ = 10σ/S

The σ is the standard deviation of the response and S is the slope of calibration graph. The detection limits were found to be 0.10, 0.21 and 1.69 μg mL-1 respectively with Sandell’s sensitivity 0.0559, 0.1034 and 1.3920 μg cm-2, respectively. Under optimum conditions, various analytical parameters were obtained (Table 1). The value of correlation coefficient indicates good linearity for all the three systems. Values of molar absorptivities and Sandell’s sensitivities reflect high sensitivity of these methods

Recovery Studies

Recovery studies were carried out for all the three drugs using calibration curve at three different concentrations over the linear range. The recoveries were found to be in vicinity of 100% (Table 2).

Drug Taken (μg mL-1) Founda(μg mL-1) %Recovery Mean±SD
Azithromycin 10.0 10.5 105.0   103.6  ± 1.3
20.0 20.5 102.5
30.0 31.5 103.3
Sparfloxacin 25.0 26.0 104.0   100.6 ± 4.4
45.0 43.0 95.6
65.0 66.5 102.3
Cephalexin monohydrate 55.0 53.0 96.4   98.6 ± 2.3
95.0 93.5 98.4
145.0 146.4 101.0

Table 2: Recovery studies of the three drugs.

Accuracy and precision

Accuracy expresses the closeness between the reference value and the found value. It was evaluated as percentage relative error between the measured concentrations and taken concentrations of these three drugs. The precision of these methods were calculated in terms of intermediate precision (intra-day and inter-day). Three concentrations of all the three drugs were analysed in three replicates during same day (intra-day precision) and three consecutive days (inter-day precision). RSD (%) values of intra-day and inter-day studies show high degree of precision (Table 3).

Drug Taken (µg mL-1) Intra-day (n=3) Inter-day (n=3)
Founda (µgmL-1) % RSD %RE Founda (µg mL-1) % RSD %RE
Azithromycin 10.0 10.5 0.5 5.0 10.3 0.8 3.0
20.0 20.5 0.3 2.5 21.0 0.4 5.0
     30.0 31.0 0.1 3.3 31.5 0.2 5.0
Sparfloxacin 25.0 26.0 6.7 4.0 26.0 6.7 4.0
45.0 43.0 3.8 4.4 43.0 3.8 4.4
65.0 66.5 3.8 2.3 66.5 3.8 2.3
55.0 53.0 0.3 3.6 54.5 4.0 0.9
95.0 93.5 1.7 1.6 95.2 2.6 0.2
145.0 146.4 0.5 1.0 147.0 1.6 1.4

Table 3: Evaluation of intraday and interday precision and accuracy.

Robustness and ruggedness

The robustness of all the three systems were evaluated by making small incremental changes in time (25 ± 5 min) and the effect of the change of absorbance were studied on the ion-pair complex. It was found that the changes had negligible influence on the results and expressed as % RSD values. The ruggedness of these methods were evaluated by performing analysis using two different cuvettes and expressed in % RSD values as shown in Table 4.

Sample Taken (μg mL-1) Robustness Reaction timea (n=3)% RSD Ruggedness Inter cuvettes (n=2)% RSD
Azithromycin 10.0 0.4 0.3
20.0 0.9 0.7
30.0 0.3 0.5
Sparfloxacin 25.0 0.8 0.4
45.0 0.2 0.6
65.0 0.8 0.5
Cephalexin monohydrate 55.0 0.5 0.7
95.0 0.2 0.6
145.0 0.6 0.3

Table 4: Evaluation of robustness and ruggedness.

Interference Studies

The effect of common excipients and other additives were tested for possible interferences in the assay. Various amount of excipients such as lactose, dextrose, cellulose, magnesium stearate, talc, starch, gelatine were added to known amount of three drugs and were examined using developed procedure. It was found that these compounds have negligible solubility in acetonitrile and methanol therefore; they did not interfere in the determination of these three drugs even when present 100 times in excess. To evaluate the selectivity of the proposed method of analysis in pharmaceutical formulations, placebo blank was compared with synthetic mixture and the results are incorporated as % RSD (Table 5).

Excipients Amount added (mg) Azithromycina
% Recovery ± SD
Cephalexin monohydrateb
% Recovery ± SD
Lactose 20 99.3 ± 0.7 98.2 ± 0.3
Dextrose 20 98.4 ± 0.9 99.5 ± 0.7
Cellulose 20 98.5 ± 0.8 101.1 ± 0.6
Magnesium stearate 20 101.2 ± 0.4 99.4 ± 0.4
Talc 20 98.4 ± 0.4 100.2 ± 0.4
Starch 20 99.5 ± 0.2 99.4 ± 0.7
Gelatine 20 100.2 ± 0.5 98.8 ± 0.6

Table 5: Determination of drugs in presence of excipients.


The proposed methods have been successfully applied for the determination of azithromycin and cephalexin monohydrate in their pharmaceutical formulation such as tablets, capsules and oral suspension. Calibration curve method and standard addition method were adopted for quantitative analysis (Table 6). Urine samples were successfully analysed with azithromycin and sparfloxacin. Quantitation was carried out using calibration graph (Table 7).

Pharmaceutical Preparation Labelled Amount (mg) Found Amount (mg)a
Calibration curve
Standard addition
Lazithro tablets b 250 249.7 ± 2.7 247.6 ± 3.4
Azee tablets c 250 260.7 ± 6.9 249.3 ± 1.1
AzithralLiquidd 20 20.2 ± 1.2 21.1 ± 1.8
Phexincapsulese 500 493.1 ± 3.0 499.1 ± 5.9
Cefftabletsf 250 247.6 ± 3.0 251.7 ± 1.9
Phexin oral suspensiong 250 254.5 ± 1.6 245.2 ± 2.7

Table 6: Analysis of pharmaceutical formulations.

Drug Taken (μg mL-1) Founda (μg mL-1) % Recovery % RSD
Azithromycin 10.0 10.5 105.0 0.7
15.0 14.5 96.7 0.7
20.0 19.5 97.5 0.8
30.0 31.0 103.3 0.4
35.0 36.0 102.9 0.1
Sparfloxacin 20.0 21.0 105.0 1.4
30.0 29.5 98.9 0.6
40.0 38.5 96.3 0.2
50.0 51.0 102.0 0.1
60.0 59.0 98.3 0.3

Table 7: Analysis of spiked urine samples.


The developed methods were found to be versatile and have many advantages over the previously reported methods. A comparison of these methods with reported methods have been presented in (Table 8). It has been observed that, bromophenol blue methods have wider linear ranges as compared to most of the reported methods [11,12,14-16,20-23]. These proposed methods are more sensitive compared to some of the established method as shown by the molar absorptivity [14]. The detection limits are lower than the reported methods [11,13,18,19,23].

Drug Reagent used Linear range
Molar absorptivity
(L mol-1 cm-1)
Applications Ref.
Azithromycin Quinalizarin 4-20 0.35 -- Tablets 12
  Eosin Y 1-10 -- -- Human urine, plasma 13
  Rose Bengal 4-20 0.31 3.78× 104 Tablets, capsules, syrup 14
  Chloranilic acid 5-225 -- 2.4×103 Tablets 15
  7,7,8,8-tetracyanoquinodimethane 0-30 -- 2.7×104
Tablets 15
  Bromophenol blue 0-50 0.10 1.369×104 Tablets, syrup, Human Urine Present work
Sparfloxacin Bromocresol purple 5-25 -- 2.988×104 Tablets 16
  Bromocresol green 5-25 -- 3.152×104 Tablets 16
  Ammonium vanadate 0.8-28 -- -- Tablets, Human Urine 17
  Mo(V)-thiocyanate 10-150 9.00 62×103 Tablets 19
  p- dimethyl amino-benzaldehyde 2-80 0.22 4.9×103 Tablets, Human urine, Blood serum 20
  Bromophenol blue 10-80 0.21 3.774×103 Human Urine Present Work
Cephalexin monohydrate Molybdenum blue 0-45 -- -- Capsules 21
  Sodium 1,2-napthoquinone-4-sulphonate 1.5-34 0.49 1.79×103 Capsules 22
  p-benzoquinone 10-160 -- 1.37×103 Capsules 23
  Iodine 6-40 1.37 9.64×103 Capsules 24
  2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 40-180 2.76 2.22×103 Capsules 24
  7,7,8,8-tetracyanoquinodimethane 4-12 0.23 31.90×103 Capsules 24

Table 8: Comparison of present work with reported methods.

These methods require only dye and solvents which are comparatively cheaper and readily available. These methods are simple as they do not involve adjustment of critical conditions like temperature, pH or tedious sample preparation. These methods have many advantages over other analytical methods due to its simplicity, sensitivity, rapidity, low cost instrumentation, accuracy, free from interference by common additives and excipients. Due to these advantages these methods can be used for quality control and routine analysis.


The authors are thankful to UGC, New Delhi for financial assistant under Start-up- Grant and RTM Nagpur University for University Research Scheme.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • 7th International Conference on Phamaceutical Auditing
    June 08-09, 2018 Baltimore, USA
  • 4th International Conference on Drug Discovery, Designing and Development
    June 27-28, 2018 Vancouver, Canada
  • 18th World Pharma Congress
    October 18-19, 2018 Warsaw, Poland

Article Usage

  • Total views: 12363
  • [From(publication date):
    June-2015 - Mar 21, 2018]
  • Breakdown by view type
  • HTML page views : 8495
  • PDF downloads : 3868

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version